6505-00-137-7746 ( SERENTIL , NDC00597-0023-01 , SERENTIL TABLETS )
NSN Information
NSN | FSC | NIIN | Item Name | INC |
---|---|---|---|---|
6505-00-137-7746 | 6505 | 001377746 | MESORIDAZINE BESYLATE TABLETS,US | 3653 |
NSN Features
MRC | Parameter | Characteristics |
---|---|---|
CQCT | PRIMARY CONTAINER TYPE | BOTTLE |
AKJA | ACTIVE MEDICAMENT MEDICINAL STRENGTH | 100.000 MILLIGRAMS MESORIDAZINE ACTIVE INGREDIENT |
CRLK | PRIMARY CONTAINER CONTENT QUANTITY | 100.000 TABLETS |
SUPP | SUPPLEMENTARY FEATURES | MEDSEP ITEM FOR DOD,BOEHRINGER INGLEIM |
Manufacturing Part Numbers (SKUs)
Part SKU | Cage | Status | RNVC | RNCC | SADC | DAC | RNAAC |
---|---|---|---|---|---|---|---|
SERENTIL | 55391 | A | 1 | 5 | 6 | 54 | |
NDC00597-0023-01 | 55391 | A | 2 | 3 | 6 | 54 | |
SERENTIL TABLETS | 55391 | A | 1 | 5 | 4 | KX |
Manufacturers
Part SKU | Cage | Manufacturer | Type | Status |
---|---|---|---|---|
SERENTIL | 55391 | BOEHRINGER INGELHEIM PHARMACEUTI | F | A |
NDC00597-0023-01 | 55391 | BOEHRINGER INGELHEIM PHARMACEUTI | F | A |
SERENTIL TABLETS | 55391 | BOEHRINGER INGELHEIM PHARMACEUTI | F | A |
FLIS Identification
PMIC | ADPE Code | CRITL Code | DEMIL Code | DEMIL INTG | NIIN Asgt | ESD | HMIC | ENAC | Schedule-B | INC |
---|---|---|---|---|---|---|---|---|---|---|
A | X | A | 1 | 07/30/1 | P | 3004909135 | 3653 |
FLIS Management
MOE | REC Rep Code | Mgmt Ctl | USC | Phrase Code | Phrase Statement |
---|---|---|---|---|---|
DN | 9L----- | N | V | DISCONTINUED W/O REPLACEMENT | |
VA | V | K | U/I CONTAINS 100 TT |
Demilitarization Codes & Management
DML | PMI | HMIC | ADP | CC | ESDC |
---|---|---|---|---|---|
A | A | P | X |
Miscellaneous Management
MOE (S_A) | SOS | AAC | QUP | UI | SLC | CIIC | RC | MCC | SVC |
---|---|---|---|---|---|---|---|---|---|
VA | I | 1 | BT | Q | U | V | |||
DN | S9M | Y | 1 | BT | Q | U | 9L----- | N |
Management Control Army
MATCAT 1 | MATCAT 2 | MATCAT 3 | MATCAT 4 5 | ARC |
---|
Freight
NMFC | NMFC SUB | UFC | HMC | LTL | LCL | WCC | TCC | SHC | ADC | ACC | ASH | NMF DESC |
---|---|---|---|---|---|---|---|---|---|---|---|---|